Competition is coming in the EpiPen controversy -- from Mylan itself. The company that makes EpiPen surprised analysts on Monday by announcing plans to launch a generic version of the allergy treatment at a 50% discount.
Ed Henry, the former White House correspondent for Fox News, is returning to the network after a nearly four-month break after a tabloid revealed he'd cheated on his wife. He'll start Monday as a general assignment reporter.
Investment bank UBS says Wall Street, energy and retail could be big winners if Donald Trump is the next president. But overall stocks and bonds would likely do better under Hillary Clinton.
St. Jude Medical called claims that its pacemakers are vulnerable to cyber attacks "absolutely untrue." Investors sound worried though, sending the company's stock dropping 8%.
